These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16813918)

  • 1. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.
    Ushijima S; Ukimura O; Okihara K; Mizutani Y; Kawauchi A; Miki T
    J Urol; 2006 Aug; 176(2):665-71. PubMed ID: 16813918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality of life assessment of the male with benign prostate hypertrophy].
    Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
    Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia.
    Homma Y; Yamaguchi T; Kondo Y; Horie S; Takahashi S; Kitamura T
    J Urol; 2002 Jan; 167(1):172-6. PubMed ID: 11743299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surgical treatment on nocturia in men with benign prostatic obstruction.
    Cai T; Gardener N; Abraham L; Boddi V; Abrams P; Bartoletti R
    BJU Int; 2006 Oct; 98(4):799-805. PubMed ID: 16978275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia.
    Agrawal CS; Chalise PR; Bhandari BB
    Nepal Med Coll J; 2008 Jun; 10(2):104-7. PubMed ID: 18828432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale.
    Batista-Miranda JE; Molinuevo B; Pardo Y
    Urology; 2007 Feb; 69(2):285-8. PubMed ID: 17320665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.
    O'Sullivan M; Murphy C; Deasy C; Iohom G; Kiely EA; Shorten G
    J Am Coll Surg; 2004 Mar; 198(3):394-403. PubMed ID: 14992742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a new treatment outcome score for men with LUTS.
    Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
    Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
    Tsukamoto T; Masumori N; Rahman M; Crane MM
    Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.
    Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
    Scand J Urol Nephrol; 2007; 41(1):32-41. PubMed ID: 17366100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
    Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
    J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.
    Donovan JL; Kay HE; Peters TJ; Abrams P; Coast J; Matos-Ferreira A; Rentzhog L; Bosch JL; Nordling J; Gajewski JB; Barbalias G; Schick E; Silva MM; Nissenkorn I; de la Rosette JJ
    Br J Urol; 1997 Nov; 80(5):712-21. PubMed ID: 9393291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The international prostate symptom score overestimates nocturia assessed by frequency-volume charts.
    van Haarst EP; Bosch JL; Heldeweg EA
    J Urol; 2012 Jul; 188(1):211-5. PubMed ID: 22591963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between lower urinary tract symptoms and erectile dysfunction.
    Aslan G; Cavus E; Karas H; Oner O; Duran F; Esen A
    Arch Androl; 2006; 52(3):155-62. PubMed ID: 16574595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Italian linguistic validation of the ureteral stent symptoms questionnaire.
    Giannarini G; Keeley FX; Valent F; Milesi C; Mogorovich A; Manassero F; Barbone F; Joshi HB; Timoney AG; Selli C
    J Urol; 2008 Aug; 180(2):624-8. PubMed ID: 18554654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 years.
    Robert G; Descazeaud A; Azzouzi R; Saussine C; Haillot O; Dumonceau O; Ballereau C; Fourmarier M; Devonec M; Lukacs B; Delongchamps NB; Desgrandchamps F; de la Taille A
    Urol Int; 2010; 84(4):424-9. PubMed ID: 20339294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.